Veradermics Q4 Loss Wider Than Last Year, Stock Falls 8%

Veradermics reported a Q4 net loss of $21.8 million, compared to $5.7 million last year, and a full-year loss of $69.9 million, compared to $26.5 million in the previous year. The company's stock fell 8% on Monday morning trading, currently trading at $60.24. The loss was attributed to increased expenses and lower revenue.